PROCEPT BioRobotics Corporation (PRCT) Institutional Ownership & Insider Trading

254 institutions reported holding PROCEPT BioRobotics Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 22 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PRCTPROCEPT BioRobotics CorporationFollow PRCT — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 1.1B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

254 institutions held 95.8% of the shares. Across filers that reported both quarters, shares held changed -2.7%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	254	55	-2.7%	102	29	62	31
Mar 26	255	56	-1.1%	88	37	61	42
Dec 25	259	57	-0.6%	104	45	52	36
Sep 25	236	58	+8.8%	84	30	61	56
Jun 25	267	53	+4.9%	116	31	76	34
Mar 25	275	50	-0.1%	88	42	90	46
Dec 24	275	50	+8.2%	110	53	72	27
Sep 24	245	46	+1.2%	73	63	70	22

PROCEPT BioRobotics Corporation — questions

Who owns PROCEPT BioRobotics Corporation stock?: 254 institutions reported PROCEPT BioRobotics Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.5%), T. Rowe Price Investment Management, Inc. (5.7%), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (4.9%).
Are PROCEPT BioRobotics Corporation insiders buying or selling?: 22 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from PROCEPT BioRobotics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.